Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ly-Mee Yu

Showing results (161-170 of 185) with videos related to

Pageof 19
Sort By:
BMJ Open|September 4, 2023
Penicillin allergy status and its effect on antibiotic prescribing, patient outcomes and antimicrobial resistance (ALABAMA): protocol for a multicentre, parallel-arm, open-label, randomised pragmatic trialKelsey Fiona Armitage, Catherine E Porter, Shadia Ahmed, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 20, 2022
Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trialJienchi Dorward, Ly-Mee Yu, Gail Hayward, et al.
The Pediatric Infectious Disease Journal|December 15, 2010
Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trialMatthew D Snape, Chaam L Klinger, Elvis D Daniels, et al.
The Lancet. Respiratory Medicine|July 30, 2021
Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trialChristopher C Butler, Ly-Mee Yu, Jienchi Dorward, et al.
Plos Neglected Tropical Diseases|August 18, 2016
Using a Human Challenge Model of Infection to Measure Vaccine Efficacy: A Randomised, Controlled Trial Comparing the Typhoid Vaccines M01ZH09 with Placebo and Ty21aThomas C Darton, Claire Jones, Christoph J Blohmke, et al.
The Lancet. Oncology|June 23, 2023
Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort studyBrian D Nicholson, Jason Oke, Pradeep S Virdee, et al.
BMJ Open|January 26, 2020
Blood pressure monitoring in high-risk pregnancy to improve the detection and monitoring of hypertension (the BUMP 1 and 2 trials): protocol for two linked randomised controlled trialsGreig Dougall, Marloes Franssen, Katherine Louise Tucker, et al.
Plos One|June 7, 2014
Streptococcus pneumoniae carriage prevalence in Nepal: evaluation of a method for delayed transport of samples from remote regions and implications for vaccine implementationSarah Hanieh, Mainga Hamaluba, Dominic F Kelly, et al.
JAMA|May 3, 2022
Effect of Self-monitoring of Blood Pressure on Blood Pressure Control in Pregnant Individuals With Chronic or Gestational Hypertension: The BUMP 2 Randomized Clinical TrialLucy C Chappell, Katherine L Tucker, Ushma Galal, et al.
The Journal of Infection|March 2, 2024
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomesGail Hayward, Ly-Mee Yu, Paul Little, et al.
Pageof 19

Showing results (161-170 of 185) with videos related to

Sort By:
Pageof 19
BMJ Open|September 4, 2023
Penicillin allergy status and its effect on antibiotic prescribing, patient outcomes and antimicrobial resistance (ALABAMA): protocol for a multicentre, parallel-arm, open-label, randomised pragmatic trialKelsey Fiona Armitage, Catherine E Porter, Shadia Ahmed, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 20, 2022
Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trialJienchi Dorward, Ly-Mee Yu, Gail Hayward, et al.
The Pediatric Infectious Disease Journal|December 15, 2010
Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trialMatthew D Snape, Chaam L Klinger, Elvis D Daniels, et al.
The Lancet. Respiratory Medicine|July 30, 2021
Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trialChristopher C Butler, Ly-Mee Yu, Jienchi Dorward, et al.
Plos Neglected Tropical Diseases|August 18, 2016
Using a Human Challenge Model of Infection to Measure Vaccine Efficacy: A Randomised, Controlled Trial Comparing the Typhoid Vaccines M01ZH09 with Placebo and Ty21aThomas C Darton, Claire Jones, Christoph J Blohmke, et al.
The Lancet. Oncology|June 23, 2023
Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort studyBrian D Nicholson, Jason Oke, Pradeep S Virdee, et al.
BMJ Open|January 26, 2020
Blood pressure monitoring in high-risk pregnancy to improve the detection and monitoring of hypertension (the BUMP 1 and 2 trials): protocol for two linked randomised controlled trialsGreig Dougall, Marloes Franssen, Katherine Louise Tucker, et al.
Plos One|June 7, 2014
Streptococcus pneumoniae carriage prevalence in Nepal: evaluation of a method for delayed transport of samples from remote regions and implications for vaccine implementationSarah Hanieh, Mainga Hamaluba, Dominic F Kelly, et al.
JAMA|May 3, 2022
Effect of Self-monitoring of Blood Pressure on Blood Pressure Control in Pregnant Individuals With Chronic or Gestational Hypertension: The BUMP 2 Randomized Clinical TrialLucy C Chappell, Katherine L Tucker, Ushma Galal, et al.
The Journal of Infection|March 2, 2024
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomesGail Hayward, Ly-Mee Yu, Paul Little, et al.
Pageof 19